IG eMediplan
IG eMediplan is a Swiss non-profit association that maintains the CHMED23A national standard for electronic medication plans, serving patients, physicians, pharmacies, hospitals, and healthcare software vendors across Switzerland.
- Company typePrivate
- Founded2014
- HeadquartersBern, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What IG eMediplan does
IG eMediplan is a Swiss non-profit association (Verein) founded in 2014 and headquartered in Bern that manages the Swiss national standard for electronic medication plans, known as the eMediplan. The organization builds and maintains the CHMED23A specification, a technical data standard that enables interoperability of medication plans across physicians, pharmacies, hospitals, and patients in Switzerland. The eMediplan addresses a meaningful Swiss healthcare problem: approximately 1.65 million Swiss residents are affected by polypharmacy, and roughly 20,000 hospital admissions annually are tied to medication-related issues.
The standard has seen rapid adoption, with cumulative eMediplans created growing from 2 million in 2023 to 3.5 million+ in 2024, and creation volume running at approximately 60,000–70,000 plans per month as of October 2023. The organization is undergoing a strategic evolution from a technical standards developer to a medical guardian of standards, and is concurrently transitioning to HL7 FHIR CH-EMED to align with broader healthcare interoperability frameworks. The September 3, 2025 approval of the Heilmittelgesetz revision by the Swiss Federal Council makes eMediplan mandatory, converting the standard from a voluntary industry initiative into a legal requirement.
As a non-profit association, IG eMediplan is funded through membership dues and sponsorships from affiliated healthcare organizations, with governance provided by a Board of Directors including co-presidents. The organization operates with a lean team of 5 employees and is supported by its multi-stakeholder membership base. It is recognized externally as the Innovationspreis der Allianz q 2025 winner and is preparing to extend the eMediplan standard into the consumer-facing isimed app by May 2026.
IG eMediplan firmographics
Firmographics- Name
- IG eMediplan
- Legal name
- IG eMediplan
- Website
- https://emediplan.ch
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IG eMediplan is a Swiss non-profit association that maintains the CHMED23A national standard for electronic medication plans, serving patients, physicians, pharmacies, hospitals, and healthcare software vendors across Switzerland.
- Ownership category
- akta.pro rank
IG eMediplan industry classification
Industry- Product category
- Healthcare Interoperability Standards
- akta.pro primary industry
- Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)
- akta.pro secondary industry
- ePrescribing Networks, Routing & Provider Enablement (HLACAKAA)
Keywords
Where IG eMediplan is headquartered
LocationHeadquarters
- HQ city
- Bern
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
IG eMediplan business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Membership and Sponsorship: IG eMediplan is financed through members and sponsors (Gönner). The association has members from healthcare professional associations, software companies, and individual supporters who pay membership fees.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
IG eMediplan product offering
Product offeringCore offering
IG eMediplan develops and maintains the Swiss national eMediplan standard — a standardized electronic medication plan format (CHMED23A) displaying complete medication in text and image format with a 2D barcode/QR code for digital exchange. The standard is available as paper printout, PDF document, or via integration into patient-facing apps and healthcare provider software systems. The organization coordinates stakeholders, supports e-prescription (eRezept) standards, and is transitioning to HL7 FHIR CH-EMED for international interoperability.
Product overview
IG eMediplan offers a single unified product: the eMediplan, which is the Swiss electronic medication plan standard. The eMediplan is available in three formats that contain identical data: (1) paper format for physical portability, (2) PDF format for email transmission or storage in the Electronic Patient Dossier (EPD), and (3) app integration through Compassana, isimed, Meine Praxis, and TOM Tabletten Erinnerung apps. The product is supported by technical standards including CHMED23A and is transitioning to HL7 FHIR CH-EMED. A 2D barcode enables healthcare professionals to quickly scan and import medication information into their systems. The organization also supports e-prescription (eRezept) standards through collaboration with FMH and pharmaSuisse.
Differentiator
Problem solved
Functional benefit
Brands
- CHMED16A: Standard specification for e-prescriptions approved by the board
- CHMED23A
Products and services
- eMediplan Standard (CHMED23A) The Swiss national electronic medication plan standard that displays complete medication in text and image format with a 2D barcode/QR code. Helps patients take medications correctly and enables healthcare professionals to quickly review current medication, preventing adverse interactions and duplicate prescriptions. Used across Switzerland's healthcare system by doctors, pharmacists, nurses, and patients.
- eMediplan PDF Format Digital PDF version of the medication plan that can be sent via email or stored in the electronic patient dossier (EPD). Contains the same standardized data as paper and app formats.
- eMediplan App Integration Digital integration of the eMediplan standard into patient-facing apps including Compassana, isimed, Meine Praxis (Apollo by healthinal), and TOM Tabletten Erinnerung, enabling smartphone management of medication plans via QR code scanning and sharing with healthcare providers.
- eMediplan Paper Format Physical paper version of the eMediplan that patients can carry anywhere or display at home. Contains the same standardized medication data and 2D barcode as digital formats, ensuring accessibility for patients without smartphones.
Quantifiable outcome
- 3.5 million eMedipläne created in 2024 (up from 2 million in 2023)
- +4 more outcomes
Companies that use IG eMediplan
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
IG eMediplan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature3 records
IG eMediplan partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and moderate.
- isimedcoreMobile health app developer expanding their app to include eMediplan functionality, allowing patients to scan, manage, and share their medication plans via smartphone.
- allianz qmoderateHealthcare quality think tank awarding Innovationspreis 2025 to IG eMediplan. allianz q brings together experts from various Swiss healthcare sectors to promote quality over cost.
- AG E-Rezept (FMH, pharmaSuisse, HIN)coreJoint initiative between Swiss Medical Association (FMH), Swiss Pharmacists Association (pharmaSuisse), and HIN for implementing electronic prescriptions in Switzerland, closely coordinated with eMediplan standards (CHMED16A). The AG E-Rezept assumed operational responsibility for eRezept implementation from IG eMediplan.
- HCI SolutionscoreHCI Solutions provides data and statistics on eMediplan usage, tracking the number of plans created quarterly. Their data shows 3.5 million eMedipläne in 2024.
- CompassanacoreDigital health platform integrating eMediplan into its patient-facing app, enabling patients to manage their medication plans digitally and share with healthcare providers.
- Meine Praxis (healthinal/Apollo)corePractice management app developer with Apollo product integrating eMediplan for seamless medication data exchange between patients and healthcare providers.
- EQK (Eidgenössische Qualitätskommission)moderateFederal Quality Commission involved in healthcare quality improvement, with ongoing procurement and projects in medication management area.
- DigiSantémoderateNational digital health initiative including e-Medikation as one of eight fields in the Swiss Health Dataspace. Dr. Katrin Crameri from DigiSanté participates in IG eMediplan events.
- Spitex SwitzerlandmoderateHome care organizations implementing eMediplan for patient medication safety in home care settings, including Spitex Region Konolfingen and Spitex Thurgau.
- Ärztegesellschaft des Kantons BernmoderateBern Cantonal Medical Association as member of IG eMediplan, supporting interprofessional collaboration and safe medication practices.
- Post CH Digital Services AGmoderateSwiss Post digital services subsidiary working on eMediplan/HL7 FHIR CH EMED integration with KISIM clinical system.
- eHealth SuissecoreNational eHealth coordination body defining Swiss eHealth standards, working with IG eMediplan on medication plan specifications and interoperability with HL7 FHIR standards.
- BAG (Bundesamt für Gesundheit)coreSwiss Federal Office of Public Health, which decided to use international standards (HL7 FHIR, IHE profiles) for eMedikation and included mandatory eMediplan in the revised Heilmittelgesetz.
- IPAG eHealthmoderateInterprofessional association for eHealth in Switzerland, coordinating with IG eMediplan on Switzerland-specific medical-pharmaceutical content for eMediplan standards.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
IG eMediplan competitors and assessment
Company assessmentRegional players
- Australian Digital Health Agency: Australian government agency responsible for national digital health strategy including electronic medication management. Comparable in role as a national-level steward of medication interoperability, operating in a different geography.
- ELGA GmbH: Austrian operator of the national electronic health record system including medication lists. Comparable as a national-scale medication interoperability infrastructure, though ELGA is a government-owned GmbH rather than an association.
- NHS England (formerly NHS Digital): UK national health authority managing NHS medication standards including the Electronic Patient Record and electronic prescription service. Comparable as a national-scale e-medication infrastructure steward, though embedded within a much larger public health system.
- Nictiz: Dutch national competence center for healthcare interoperability, supporting standards like HL7 FHIR for medication data exchange. Comparable in role to IG eMediplan as a national-level eHealth standards steward, but operating in the Netherlands.
Direct peers
- HL7 International: Global standards body for healthcare interoperability including FHIR. IG eMediplan is migrating toward HL7 FHIR CH-EMED standards, making HL7 International the most directly comparable peer in terms of standards-setter role and scope.
- IHE International (Integrating the Healthcare Enterprise): International initiative defining interoperability profiles for healthcare systems. IG eMediplan's CHMED23A aligns with IHE profiles, and BAG mandated IHE profiles for eMedikation — making IHE International a direct functional peer in profile/spec development.
- eHealth Suisse: Swiss national coordination body for eHealth under federal mandate, working jointly with IG eMediplan on medication plan specifications and HL7 FHIR standards. Operates as a quasi-governmental standards coordinator with overlapping scope.
- IPAG eHealth (Interprofessionelle Arbeitsgruppe eHealth): Swiss interprofessional association coordinating medical-pharmaceutical content for eMediplan standards. Shares the multi-stakeholder governance model and Swiss national scope with IG eMediplan, serving as a strategic coordination partner.
Broad incumbents
- SNOMED International: International not-for-profit governing SNOMED CT clinical terminology standards used in medication documentation. Operates as a larger, more established standards organization with comparable non-profit governance model but at global scale.
- ISO/TC 215 (Health Informatics): International standards committee for health informatics covering interoperability, medication records, and terminology. Comparable as a higher-level standards body whose work intersects with IG eMediplan's CHMED23A specifications.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
IG eMediplan social profiles
Digital presenceIG eMediplan compliance and trust
Trust signalCompliance1 record
IG eMediplan financial estimates
Financial estimateRevenue estimate
Valuation estimate
IG eMediplan leadership team
Management profileNumber of profiles
Profiles9 records
IG eMediplan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IG eMediplan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IG eMediplan
What does IG eMediplan do?
IG eMediplan develops and maintains the Swiss national eMediplan standard — a standardized electronic medication plan format (CHMED23A) displaying complete medication in text and image format with a 2D barcode/QR code for digital exchange. The standard is available as paper printout, PDF document, or via integration into patient-facing apps and healthcare provider software systems. The organization coordinates stakeholders, supports e-prescription (eRezept) standards, and is transitioning to HL7 FHIR CH-EMED for international interoperability.
Is IG eMediplan a public or private company?
IG eMediplan is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was IG eMediplan founded?
IG eMediplan was founded in 2014. It employs 1 to 10 people.
Where is IG eMediplan based?
IG eMediplan is headquartered in Bern, Switzerland, in the Europe region.
How does IG eMediplan make money?
One revenue line is on record: membership and Sponsorship.
Who are IG eMediplan's main competitors?
Regional players on record are Australian Digital Health Agency, ELGA GmbH, NHS England (formerly NHS Digital) and Nictiz. Direct peers are HL7 International, IHE International (Integrating the Healthcare Enterprise), eHealth Suisse and IPAG eHealth (Interprofessionelle Arbeitsgruppe eHealth). Broad incumbents are SNOMED International and ISO/TC 215 (Health Informatics).
Does IG eMediplan have an API?
No public API is recorded for IG eMediplan.
What industry is IG eMediplan in?
IG eMediplan's product category is Healthcare Interoperability Standards. Its primary akta.pro industry code is HLACABAA, Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE), with a secondary code of HLACAKAA, ePrescribing Networks, Routing & Provider Enablement.